DIA Biosimilars 2013

sanofi

Sanofi teams up with Medco Health Solutions, UBC

Friday, June 24, 2011 10:29 AM

Sanofi is looking for more ‘real-world’ insight into its drug development and product lifecycle strategies by teaming up with pharmacy benefit manager Medco Health Solutions to help deliver value propositions that can withstand tough scrutiny from regulators and payers, reports PharmaTimes.

More... »

Cenduit: Now with Patient Reminders

Sanofi collaborates with Audion Therapeutics

Friday, June 17, 2011 02:25 PM

Paris-based Sanofi has entered into a two-year research collaboration with biopharmaceutical company Audion Therapeutics to develop potential treatments for hearing loss through the optimization of small molecules by using a regenerative medicine approach.

More... »

CRF Health – eCOA Forum

Sanofi: Genzyme unit may be smaller

Thursday, June 2, 2011 11:16 AM

Sanofi has told employees of Cambridge, Mass.-based Genzyme, the biotech Sanofi acquired in April, that they will have a new reporting structure within the parent company, according to The Boston Globe.

More... »

Sanofi, DNDi collaborate on new drugs for neglected tropical diseases

Tuesday, May 31, 2011 03:35 PM

French health care company Sanofi has announced a three-year research collaboration agreement with Drugs for Neglected Diseases initiative or DNDi, an independent, nonprofit product development partnership, according to RTT News.

More... »

Quintiles’ Chasse, Sanofi Pasteur’s Milam make unprecedented industry move to the site world

Monday, May 23, 2011 08:44 AM

Christine Pierre, president of the investigator site group and consultancy RxTrials, shocked parts of the industry this month when she hired Adam Chasse away from global CRO Quintiles and Dan Milam from Sanofi Pasteur, the largest company in the world devoted to vaccines.

More... »

Sanofi signs deal with Glenmark

Monday, May 16, 2011 12:59 PM

France-based Sanofi has licensed a potential treatment for Crohn's disease from India's Glenmark Pharmaceuticals, according to Pharma Times.

More... »

Sanofi-Aventis changes name

Monday, May 9, 2011 01:01 PM

Sanofi-Aventis will change the company’s name to just Sanofi, immediately, according to Pharma Times.

More... »

Bayer CEO considers merger only if stars are aligned

Thursday, May 5, 2011 12:40 PM

German-based Bayer is open to a “merger of equals” that would enhance its health-care unit without paying a premium for an acquisition, says Bayer’s chief executive officer Marijn Dekkers, according to a Bloomberg report.

More... »

Sanofi, Regeneron show positive results for Zaltrap

Wednesday, April 27, 2011 02:13 PM

Partners Sanofi-Aventis and Regeneron Pharmaceuticals report positive results for a late stage study evaluating Zaltrap (aflibercept), a colorectal cancer candidate.  

More... »

Sanofi-aventis collaborates with Stanford University

Monday, April 18, 2011 12:49 PM

Sanofi-aventis has entered into a research collaboration agreement that will last several years through the Stanford University Bio-X program, according to Fierce Biotech.  The Stanford program supports, organizes, and facilitates interdisciplinary, collaborative and innovative research projects in the early phases of development.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs